Haleon confirms 2025 outlook despite mixed Q3 performance By Investing.com
Update: 2025-10-30
Description
Haleon, a leading global consumer health company, reported its Q3 results, maintaining its full-year outlook. Despite mixed regional performance, the company expects a 3.5% organic revenue growth for the year, surpassing expert expectations. North America shone with increased market share and stronger-than-forecasted growth, while Latin America, particularly Colombia and Mexico, also performed well. However, Asia-Pacific, especially North Asia, underperformed due to retailer inventory quirks. India, though, showed double-digit growth. Haleon anticipates growth next year as inventory levels normalize, driven by its strong brands and global presence. The company aims for high-single-digit operating profit growth and maintains its medium-term organic revenue growth target of 4-6%, assuming a typical cold and flu season.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
